Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,398 | -8,068 | -4,409 | -22,686 | -18,399 |
| Depreciation Amortization | 1,848 | 1,187 | 602 | 2,858 | 2,198 |
| Accounts receivable | -316 | -274 | -747 | 1,129 | 991 |
| Other Working Capital | -385 | -616 | -803 | -1,037 | -399 |
| Other Operating Activity | -236 | 931 | 1,238 | 1,608 | 1,705 |
| Operating Cash Flow | $-9,487 | $-6,840 | $-4,119 | $-18,128 | $-13,904 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -128 | -78 | -53 | -182 | -261 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,201 | -1,201 |
| Other Investing Activity | 0 | 0 | 0 | -1,201 | -1,201 |
| Investing Cash Flow | $-128 | $-78 | $-53 | $-1,383 | $-1,462 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | 0 | N/A | -4,720 | -4,720 |
| Common Stock Issued | 6,246 | -200 | -150 | 23,613 | 12,377 |
| Other Financing Activity | 0 | 0 | 0 | -2,078 | 0 |
| Financing Cash Flow | $6,246 | $-200 | $-150 | $16,815 | $7,657 |
| Exchange Rate Effect | -10 | 12 | 39 | 11 | 11 |
| Beginning Cash Position | 10,225 | 10,225 | 10,225 | 12,910 | 12,910 |
| End Cash Position | 6,846 | 3,119 | 5,942 | 10,225 | 5,212 |
| Net Cash Flow | $-3,379 | $-7,106 | $-4,283 | $-2,685 | $-7,698 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,487 | -6,840 | -4,119 | -18,128 | -13,904 |
| Capital Expenditure | -128 | -78 | -53 | -295 | -271 |
| Free Cash Flow | -9,615 | -6,918 | -4,172 | -18,423 | -14,175 |